Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Long-term antidepressant use surges in Australia, sparking warnings of overprescribing

Written by | 15 Dec 2025

Long-term antidepressant use in Australia has risen steadily over the past decade, with the largest increase seen in young people aged 10-24, where rates have more than doubled…. read more.

Large paracetamol study offers reassurance

Written by | 9 Dec 2025

A rigorous systematic review of the use of paracetamol (also known as acetaminophen) during pregnancy has found that the common painkiller does not increase the risk of specific… read more.

Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in children

Written by | 21 Nov 2025

Existing evidence does not clearly link paracetamol (acetaminophen) use during pregnancy with autism or ADHD in children, finds an in-depth evidence review published by The BMJ today, in direct response… read more.

Meta-analysis offers reassurance that pregnant women can safely use acetaminophen

Written by | 16 Nov 2025

A rigorous systematic review of the present state of knowledge on the use of acetaminophen during pregnancy and the risk of specific neurodevelopmental disorders (NDDs), such as autism… read more.

Common heartburn and blood pressure medicines linked to adverse breast cancer outcomes in large global study

Written by | 14 Nov 2025

A major international study involving 23,000 people has found concerning evidence about the impact of a range of common, everyday medications on the treatment outcomes for patients with… read more.

Fluorine “forever chemical” in medicines not leading to added drug reactions

Written by | 8 Sep 2025

Medicines containing a type of PFAS or ‘forever chemical’ called fluorine are not leading to higher numbers of adverse drug reactions according to new data analysis. In a… read more.

GLP-1 RA medications safe and effective for treating obesity in adults with mental illness

Written by | 25 May 2025

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive… read more.

Local access to abortion services expanded with mifepristone in community pharmacies

Written by | 9 Apr 2025

Before 2017, abortions were generally performed as procedures in fewer than 100 hospitals and clinics mostly in urban centres, leading to delayed care, particularly for people living in rural… read more.

Testing patients for just three genes could help prevent three quarters of avoidable side effects of certain medications

Written by | 4 Apr 2025

A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with… read more.

Obesity Action Coalition & The Obesity Society send letter to FDA on behalf of more than 20 leading organizations & providers urging enforcement of compounding regulations

Written by | 25 Mar 2025

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading… read more.

New medication sinus thrombosis just as safe but more patient-friendly

Written by | 2 Mar 2025

Patients affected by sinus thrombosis are treated with blood thinners. Traditionally, these patients are prescribed vitamin K antagonists (VKAs). In order to give the correct dosage, regular check-ups… read more.

All generic drugs are not equal, study finds

Written by | 1 Mar 2025

Generic drugs manufactured in India are linked to significantly more “severe adverse events” for patients who use them than equivalent drugs produced in the United States, a new… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.